Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Kraft

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|May 17, 2008
Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3'-untranslated regionKarthikeyan Kandasamy, Andrew S Kraft
Pharmacology & Therapeutics|March 10, 2015
PIM kinase (and Akt) biology and signaling in tumorsNoel A Warfel, Andrew S Kraft
Blood|May 23, 2024
SMACing down relapsed T-ALLEric M Sawyer, Andrew S Kraft
Cancer Research|November 15, 2011
Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737Jin H Song, Andrew S Kraft
Blood|May 6, 2021
"Root"ing for successful T-ALL treatmentSathish K R Padi, Andrew S Kraft
Oncogene|February 19, 2002
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cellsAlexandre Nesterov, Yuri Ivashchenko, Andrew S Kraft
Journal of Hematology & Oncology|January 31, 2013
Abnormal hematopoietic phenotypes in Pim kinase triple knockout miceNingfei An, Andrew S Kraft, Yubin Kang
The Journal of Biological Chemistry|October 12, 2004
Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylationYouhong Zhang, Joseph R Biggs, Andrew S Kraft
The Journal of Biological Chemistry|July 5, 2008
ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosisJin H Song, Karthikeyan Kandasamy, Andrew S Kraft
Cancer Biology & Therapy|July 21, 2006
Combination of gemcitabine antagonizes antitumor activity of paclitaxel through prevention of mitotic arrest and apoptosisMeihua Sui, Xiaoxiong Xiong, Andrew S Kraft, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|May 17, 2008
Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3'-untranslated regionKarthikeyan Kandasamy, Andrew S Kraft
Pharmacology & Therapeutics|March 10, 2015
PIM kinase (and Akt) biology and signaling in tumorsNoel A Warfel, Andrew S Kraft
Blood|May 23, 2024
SMACing down relapsed T-ALLEric M Sawyer, Andrew S Kraft
Cancer Research|November 15, 2011
Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737Jin H Song, Andrew S Kraft
Blood|May 6, 2021
"Root"ing for successful T-ALL treatmentSathish K R Padi, Andrew S Kraft
Oncogene|February 19, 2002
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cellsAlexandre Nesterov, Yuri Ivashchenko, Andrew S Kraft
Journal of Hematology & Oncology|January 31, 2013
Abnormal hematopoietic phenotypes in Pim kinase triple knockout miceNingfei An, Andrew S Kraft, Yubin Kang
The Journal of Biological Chemistry|October 12, 2004
Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylationYouhong Zhang, Joseph R Biggs, Andrew S Kraft
The Journal of Biological Chemistry|July 5, 2008
ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosisJin H Song, Karthikeyan Kandasamy, Andrew S Kraft
Cancer Biology & Therapy|July 21, 2006
Combination of gemcitabine antagonizes antitumor activity of paclitaxel through prevention of mitotic arrest and apoptosisMeihua Sui, Xiaoxiong Xiong, Andrew S Kraft, et al.
Pageof 7